Welcome to LookChem.com Sign In|Join Free
  • or
3-(1-deoxyribofuranosyl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

138385-29-2

Post Buying Request

138385-29-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138385-29-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 138385-29-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,3,8 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 138385-29:
(8*1)+(7*3)+(6*8)+(5*3)+(4*8)+(3*5)+(2*2)+(1*9)=152
152 % 10 = 2
So 138385-29-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO5/c13-12(17)7-3-1-2-6(4-7)11-10(16)9(15)8(5-14)18-11/h1-4,8-11,14-16H,5H2,(H2,13,17)/t8-,9-,10-,11+/m1/s1

138385-29-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]benzamide

1.2 Other means of identification

Product number -
Other names Benzamide riboside

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138385-29-2 SDS

138385-29-2Relevant academic research and scientific papers

Probing binding requirements of NAD kinase with modified substrate (NAD) analogues

Bonnac, Laurent,Chen, Liqiang,Pathak, Rashmi,Gao, Guangyao,Ming, Qian,Bennett, Eric,Felczak, Krzysztof,Kullberg, Martin,Patterson, Steven E.,Mazzola, Francesca,Magni, Giulio,Pankiewicz, Krzysztof W.

, p. 1512 - 1515 (2007)

Synthesis of novel NAD+ analogues that cannot be phosphorylated by NAD kinase is reported. In these analogues the C2′ hydroxyl group of the adenosine moiety was replaced by fluorine in the ribo or arabino configuration (1 and 2, respectively) or was inverted into arabino configuration to give compound 3. Compounds 1 and 2 showed inhibition of human NAD kinase, whereas analogue 3 inhibited both the human and Mycobacterium tuberculosis NAD kinase. An uncharged benzamide adenine dinucleotide (BAD) was found to be the most potent competitive inhibitor (Ki = 90 μM) of the human enzyme reported so far.

Chemoselective and Diastereoselective Synthesis of C-Aryl Nucleoside Analogues by Nickel-Catalyzed Cross-Coupling of Furanosyl Acetates with Aryl Iodides

Li, Chao,Li, Luyang,Li, Yuxi,Shao, Feng,Tian, Xiaoying,Wang, Zheng

supporting information, (2021/11/30)

Canonical nucleosides are vulnerable to enzymatic and chemical degradation, yet their stable mimics—C-aryl nucleosides—have demonstrated potential utility in medicinal chemistry, chemical biology, and synthetic biology, although current synthetic methods remain limited in terms of scope and selectivity. Herein, we report a cross-electrophile coupling to prepare C-aryl nucleoside analogues from readily available furanosyl acetates and aryl iodides. This nickel-catalyzed modular approach is characterized by mild reaction conditions, broad substrate scope, excellent β-selectivity, and high functional-group compatibility. The exclusive chemoselectivity with respect to the aryl iodide enables efficient preparation of a variety of C-aryl halide furanosides suitable for various downstream transformations. The practicality of this transformation is demonstrated through the synthesis of a potent analogue of a naturally occurring NF-κB activator.

Chemical Proteomics Approach for Profiling the NAD Interactome

?ileikyt?, Justina,Sundalam, Sunil,David, Larry L.,Cohen, Michael S.

, p. 6787 - 6791 (2021/05/29)

Nicotinamide adenine dinucleotide (NAD+) is a multifunctional molecule. Beyond redox metabolism, NAD+ has an equally important function as a substrate for post-translational modification enzymes, the largest family being the poly-ADP-ribose polymerases (PARPs, 17 family members in humans). The recent surprising discoveries of noncanonical NAD (NAD+/NADH)-binding proteins suggests that the NAD interactome is likely larger than previously thought; yet, broadly useful chemical tools for profiling and discovering NAD-binding proteins do not exist. Here, we describe the design, synthesis, and validation of clickable, photoaffinity labeling (PAL) probes, 2- and 6-ad-BAD, for interrogating the NAD interactome. We found that 2-ad-BAD efficiently labels PARPs in a UV-dependent manner. Chemical proteomics experiments with 2- and 6-ad-BAD identified known and unknown NAD+/NADH-binding proteins. Together, our study shows the utility of 2- and 6-ad-BAD as clickable PAL NAD probes.

Synthesis of benzamide-C-ribonucleosides by Pd-catalyzed aminocarbonylations

?tefko, Martin,Pohl, Radek,Hocek, Michal

experimental part, p. 4471 - 4483 (2009/10/17)

A novel modular, efficient and practical methodology for preparation of p- and m-substituted benzamide-C-ribonucleosides was developed. Reaction of TBS-protected 3- and 4-bromophenyl-C-ribonucleosides 1 and 4 with various primary and secondary amines or N

The synthesis and biological evaluation of benzamide riboside and its phosphordiamidates prodrugs

Zhou, Jianning,Tan, Chunyan,Zhang, Nan,Fan, Jian,Guo, Chun,Jiang, Yuyang

scheme or table, p. 787 - 790 (2009/04/06)

In order to overcome the drug resistance and enhance the membrane penetration ability of benzamide riboside [BR, (1-β-D-ribofuranosyl) benzene-3-carboxamide], which is a novel C-glycoside analogue of nicotinamide riboside and has excellent cytotoxic activity, we designed and synthesized two phosphordiamidates (1a and 1b) as prodrugs to deliver phosphorylated BR into cells. However, the bioactivity evaluation shows that 1a and 1b have lower biological activity (IC50 > 200 μM and 173 μM, respectively) compared to BR. This might be due to the fact that 1a and 1b could only serve as the BR depot form and thus could not be metabolized to the phosporylatd benzamide riboside. Copyright Taylor & Francis Group, LLC.

Efficient synthesis of benzamide riboside, a potential anticancer agent

Bonnac, Laurent F.,Gao, Guang-Yao,Chen, Liqiang,Patterson, Steven E.,Jayaram, Hiremagalur N.,Pankiewicz, Krzysztof W.

, p. 1249 - 1253 (2008/09/19)

An efficient five step synthesis of benzamide riboside (BR) amenable for a large scale synthesis has been developed. It allows for extensive pre-clinical studies of BR as a potential anticancer agent. Copyright Taylor & Francis Group, LLC.

Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogues

Krohn,Heins,Wielckens

, p. 511 - 517 (2007/10/02)

The C-glycosidic nicotinamide riboside analogue (2) was prepared by reaction of ribonolactone 24 with the lithiated oxazoline 19 followed by triethylsilane reduction to 26 and deprotection. Selective phosphorylation to the pseudonucleotide 34 was effected

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 138385-29-2